OpenAlex
PricingAboutJobs
Log inGet started
Work

Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.

PubMed

Year: 2003
Type: article
Study design: Observational Study
Source: PubMed
Authors: Sarah Marktel, David Marin, Nicola Foot, Richard Szydlo, Marco Bua, Anastasios Karadimitris, Valeria A S De Melo, Paul Kotzampaltiris, Francesco Dazzi, Amin Rahemtulla, Eduardo Olavarria, Jane F Apperley, John M Goldman
Institutions: Hammersmith Hospital, Imperial College London
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, chronic phase, imatinib mesylate, clonal evolution, disease progression, progression-free survival, complete hematologic remission, Philadelphia chromosome, tyrosine kinase inhibitor resistance
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2188180571
FWCI: 5.629
Cites: 25
Cited by: 109
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security